Literature DB >> 19492161

Monitoring thrombin generation: is addition of corn trypsin inhibitor needed?

Henri M H Spronk1, Arne W J H Dielis, Marina Panova-Noeva, René van Oerle, José W P Govers-Riemslag, Karly Hamulyák, Anna Falanga, Hugo Ten Cate.   

Abstract

Thrombin generation monitoring has the potential to be used as a clinical diagnostic tool in the near future. However, robust preanalytical conditions may be required, and one factor that has been reported is in-vitro contact activation that might influence in-vitro measurements of thrombin generation and thereby act as an unpredictable pre-analytical variable. The aim of the current study was to investigate the influence of contact activation and the necessity of corn trypsin inhibitor (CTI) to abolish contact activation in thrombin generation measurements at low tissue factor (TF) concentrations. Thrombin generation was performed using the calibrated automated thrombinoscopy (CAT), thereby determining the endogenous thrombin potential (ETP), peak height, and the lag time, in plasma obtained from healthy volunteers. Addition of CTI after plasma preparation had no significant influence on thrombin generation triggered with 0.5 pM TF or higher, as demonstrated by unaltered ETP and lag time values between analyses with and without CTI. Addition of CTI before blood collection reduced thrombin generation triggered with 0.5 pM TF: both the ETP and peak height were significantly reduced compared to no CTI addition. In contrast, thrombin generation remained unaltered at a 1 pM TF trigger or above. This study demonstrates that addition of CTI after plasma separation is not necessary when triggering with TF concentrations of 0.5 pM and higher. Furthermore, it was demonstrated that it is not needed to pre-fill blood collecting tubes with CTI when measuring thrombin generation at TF concentrations of >/=1 pM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19492161

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  19 in total

1.  The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: comment.

Authors:  S Butenas; K G Mann
Journal:  J Thromb Haemost       Date:  2015-01-14       Impact factor: 5.824

2.  Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH.

Authors:  Y Dargaud; A S Wolberg; E Gray; C Negrier; H C Hemker
Journal:  J Thromb Haemost       Date:  2017-06-28       Impact factor: 5.824

3.  Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography.

Authors:  Marina Marchetti; Erika Diani; Hugo ten Cate; Anna Falanga
Journal:  Haematologica       Date:  2012-03-14       Impact factor: 9.941

4.  Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis.

Authors:  Koji Yada; Keiji Nogami; Kenichi Ogiwara; Yasuaki Shida; Shoko Furukawa; Hiroaki Yaoi; Masahiro Takeyama; Ryu Kasai; Midori Shima
Journal:  Int J Hematol       Date:  2019-06-28       Impact factor: 2.490

5.  Interconnectedness of global hemostasis assay parameters in simultaneously evaluated thrombin generation, fibrin generation and clot lysis in normal plasma.

Authors:  Kevin Z Xin; William C Chang; Mikhail V Ovanesov
Journal:  Thromb Res       Date:  2015-11-19       Impact factor: 3.944

6.  Characterization of the hypercoagulable state in patients with sickle cell disease.

Authors:  Nirmish Shah; Courtney Thornburg; Marilyn J Telen; Thomas L Ortel
Journal:  Thromb Res       Date:  2012-09-07       Impact factor: 3.944

7.  Monitoring rFVIII prophylaxis dosing using global haemostasis assays.

Authors:  M A Al Hawaj; E J Martin; J Venitz; J C Barrett; J G Kuhn; M E Nolte; D F Brophy
Journal:  Haemophilia       Date:  2013-03-19       Impact factor: 4.287

8.  Continuous thrombin generation in whole blood: New applications for assessing activators and inhibitors of coagulation.

Authors:  Shannon M Prior; Kenneth G Mann; Kalev Freeman; Saulius Butenas
Journal:  Anal Biochem       Date:  2018-05-07       Impact factor: 3.365

9.  Thrombin generation in the Glasgow Myocardial Infarction Study.

Authors:  Machiel Smid; Arne W J H Dielis; Henri M H Spronk; Ann Rumley; Rene van Oerle; Mark Woodward; Hugo ten Cate; Gordon Lowe
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.

Authors:  Natalia V Zakharova; Elena O Artemenko; Nadezhda A Podoplelova; Anastasia N Sveshnikova; Irina A Demina; Fazly I Ataullakhanov; Mikhail A Panteleev
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.